Stay updated on INOXT for ASD Clinical Trial
Sign up to get notified when there's something new on the INOXT for ASD Clinical Trial page.

Latest updates to the INOXT for ASD Clinical Trial page
- Check7 days agoChange DetectedAn addition of 'Revision: v3.4.2' and a deletion of 'Revision: v3.4.1' are shown, indicating a minor version update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1; no study details or functionality changed — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor metadata update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedOntario and other locations are now listed under Locations (Hamilton and Toronto), clarifying where the study is being conducted. The HHS Vulnerability Disclosure link and the older Ontario Locations entry were removed.SummaryDifference0.2%

- Check87 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange DetectedThe notice about government funding/operating status was removed from the page, while the study details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%

Stay in the know with updates to INOXT for ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INOXT for ASD Clinical Trial page.